Main | CYTR CytRx Corporation + 145% first Quarter »
Dendreon – DNDN +210% – first quarter winner
By Martin | April 2, 2007
A biotechnology company, engaged in the discovery, development, and commercialization of therapeutics that harness the immune system to fight cancer.
DNDN is the first quarter winner.
Topics: Healthcare | No Comments »
Trackback URL for this post: http://www.tradingpattern.net/2007/04/02/dendreon-dndn-150-first-quarter-winner/trackback/
Comments
You must be logged in to post a comment.





